| Targeting folate receptor alpha for cancer treatment A Cheung, HJ Bax, DH Josephs, KM Ilieva, G Pellizzari, J Opzoomer, ... Oncotarget 7 (32), 52553, 2016 | 441 | 2016 |
| Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma DO Khair, HJ Bax, S Mele, S Crescioli, G Pellizzari, A Khiabany, ... Frontiers in immunology 10, 453, 2019 | 235 | 2019 |
| BRAF inhibitors: resistance and the promise of combination treatments for melanoma M Griffin, D Scotto, DH Josephs, S Mele, S Crescioli, HJ Bax, G Pellizzari, ... Oncotarget 8 (44), 78174, 2017 | 107 | 2017 |
| Anti-folate receptor alpha–directed antibody therapies restrict the growth of triple-negative breast cancer A Cheung, J Opzoomer, KM Ilieva, P Gazinska, RM Hoffmann, H Mirza, ... Clinical Cancer Research 24 (20), 5098-5111, 2018 | 80 | 2018 |
| Anti-folate receptor-α IgE but not IgG recruits macrophages to attack tumors via TNFα/MCP-1 signaling DH Josephs, HJ Bax, T Dodev, M Georgouli, M Nakamura, G Pellizzari, ... Cancer research 77 (5), 1127-1141, 2017 | 75 | 2017 |
| AllergoOncology: opposite outcomes of immune tolerance in allergy and cancer E Jensen‐Jarolim, HJ Bax, R Bianchini, S Crescioli, TR Daniels‐Wells, ... Allergy 73 (2), 328-340, 2018 | 66 | 2018 |
| IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states G Pellizzari, C Hoskin, S Crescioli, S Mele, J Gotovina, G Chiaruttini, ... EBioMedicine 43, 67-81, 2019 | 64 | 2019 |
| Basophils from cancer patients respond to immune stimuli and predict clinical outcome HJ Bax, J Chauhan, C Stavraka, A Khiabany, M Nakamura, G Pellizzari, ... Cells 9 (7), 1631, 2020 | 30 | 2020 |
| Abstract CT141: Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancer J Spicer, B Basu, A Montes, U Banerji, R Kristeleit, GJ Veal, C Corrigan, ... Cancer research 80 (16_Supplement), CT141-CT141, 2020 | 23 | 2020 |
| Harnessing therapeutic IgE antibodies to re-educate macrophages against cancer G Pellizzari, HJ Bax, DH Josephs, J Gotovina, E Jensen-Jarolim, ... Trends in molecular medicine 26 (6), 615-626, 2020 | 22 | 2020 |
| Therapeutic targets and new directions for antibodies developed for ovarian cancer HJ Bax, DH Josephs, G Pellizzari, JF Spicer, A Montes, SN Karagiannis MAbs 8 (8), 1437-1455, 2016 | 22 | 2016 |
| Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma. Front Immunol. 2019; 10: 453 DO Khair, HJ Bax, S Mele, S Crescioli, G Pellizzari, A Khiabany, ... | 20 | 2019 |
| Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology S Crescioli, G Chiaruttini, S Mele, KM Ilieva, G Pellizzari, DIR Spencer, ... Journal of Allergy and Clinical Immunology 141 (4), 1519-1523. e9, 2018 | 20 | 2018 |
| Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2 G Pellizzari, O Martinez, S Crescioli, R Page, A Di Meo, S Mele, ... Journal for Immunotherapy of Cancer 9 (6), 2021 | 16 | 2021 |
| Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate HJ Bax, A Khiabany, C Stavraka, G Pellizzari, C Chan Wah Hak, ... Allergy 75 (8), 2069-2073, 2020 | 16 | 2020 |
| In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model IP Williams, S Crescioli, HS Sow, HJ Bax, C Hobbs, KM Ilieva, E French, ... MAbs 12 (1), 1685349, 2020 | 16 | 2020 |
| Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines’ Toxic Effects M Pelin, S De Iudicibus, L Fusco, E Taboga, G Pellizzari, C Lagatolla, ... Chemical research in toxicology 28 (6), 1186-1195, 2015 | 15 | 2015 |
| Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4 J Chauhan, M Grandits, LCGF Palhares, S Mele, M Nakamura, ... Nature communications 14 (1), 2192, 2023 | 13 | 2023 |
| Targeting folate receptor alpha for cancer treatment. Oncotarget 7, 52553–52574 A Cheung, HJ Bax, DH Josephs, KM Ilieva, G Pellizzari, J Opzoomer, ... | 12 | 2016 |
| Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro J Gotovina, R Bianchini, J Fazekas‐Singer, I Herrmann, G Pellizzari, ... Allergy 75 (11), 2939, 2020 | 9 | 2020 |
